Literature DB >> 21469761

Pseudomonas skin infection: clinical features, epidemiology, and management.

Douglas C Wu1, Wilson W Chan, Andrei I Metelitsa, Loretta Fiorillo, Andrew N Lin.   

Abstract

Pseudomonas aeruginosa is a Gram-negative bacillus that is most frequently associated with opportunistic infection, but which can also present in the otherwise healthy patient. The range of P. aeruginosa infections varies from localized infections of the skin to life-threatening systemic disease. Many P. aeruginosa infections are marked by characteristic cutaneous manifestations. The aim of this article is to provide a comprehensive synthesis of the current knowledge of cutaneous manifestations of P. aeruginosa infection with specific emphasis on clinical features and management. The ability of P. aeruginosa to rapidly acquire antibacterial resistance is an increasingly well recognized phenomenon, and the correct application of antipseudomonal therapy is therefore of the utmost importance. A detailed discussion of currently available anti-pseudomonal agents is included, and the benefits of antimicrobial combination therapy versus monotherapy are explored. Rapid clinical recognition of P. aeruginosa infection aided by the identification of characteristic cutaneous manifestations can play a critical role in the successful management of potentially life-threatening disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469761     DOI: 10.2165/11539770-000000000-00000

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  33 in total

1.  Deletion mutant library for investigation of functional outputs of cyclic diguanylate metabolism in Pseudomonas aeruginosa PA14.

Authors:  Dae-Gon Ha; Megan E Richman; George A O'Toole
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

2.  Toe web malodorous maceration with well-demarcated punch-out edge.

Authors:  Cheng Tan; Lu-Lu Zhang; Zhong-Sheng Min
Journal:  Int Wound J       Date:  2014-06-26       Impact factor: 3.315

3.  Green nail syndrome treated with the application of tobramycin eye drop.

Authors:  Youin Bae; Gang Mo Lee; Ji Hoon Sim; Sanghoon Lee; Sung Yul Lee; Young Lip Park
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

4.  Anti-quorum sensing and antibiofilm potential of 1,8-cineole derived from Musa paradisiaca against Pseudomonas aeruginosa strain PAO1.

Authors:  Vijayakumar Karuppiah; Ramanathan Thirunanasambandham; Gunasekaran Thangaraj
Journal:  World J Microbiol Biotechnol       Date:  2021-03-19       Impact factor: 3.312

5.  Arginine-rich self-assembling peptides as potent antibacterial gels.

Authors:  Ana Salomé Veiga; Chomdao Sinthuvanich; Diana Gaspar; Henri G Franquelim; Miguel A R B Castanho; Joel P Schneider
Journal:  Biomaterials       Date:  2012-09-17       Impact factor: 12.479

6.  Environmental reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa.

Authors:  Victoria Rutherford; Kelly Yom; Egon A Ozer; Olivia Pura; Ami Hughes; Katherine R Murphy; Laura Cudzilo; David Mitchell; Alan R Hauser
Journal:  Environ Microbiol Rep       Date:  2018-08       Impact factor: 3.541

Review 7.  Microbiology of the skin and the role of biofilms in infection.

Authors:  Steven L Percival; Charlotte Emanuel; Keith F Cutting; David W Williams
Journal:  Int Wound J       Date:  2011-10-05       Impact factor: 3.315

Review 8.  Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.

Authors:  Ané Orchard; Sandy van Vuuren
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-04       Impact factor: 2.629

9.  Pseudomonas aeruginosa directly shunts β-oxidation degradation intermediates into de novo fatty acid biosynthesis.

Authors:  Yanqiu Yuan; Jennifer A Leeds; Timothy C Meredith
Journal:  J Bacteriol       Date:  2012-06-29       Impact factor: 3.490

10.  Evolution of Pseudomonas aeruginosa virulence as a result of phage predation.

Authors:  Zeinab Hosseinidoust; Theo G M van de Ven; Nathalie Tufenkji
Journal:  Appl Environ Microbiol       Date:  2013-07-26       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.